5 Patents
- US122959852025Methods of Reducing Severity of Glaucoma by Intravitreal Administration of Insulin-like Growth Factor Binding Protein-like 1 (IGFBPL1)
The Schepens Eye Research Institute, Inc.
0 cites - US122342822025Therapy for Glaucoma and Optic Neuropathy by Targeting Colony Stimulating Factors
The Schepens Eye Research Institute, Inc.
0 cites - 0 cites
- US116920292023Therapy for Glaucoma and Optic Neuropathy by Targeting Colony Stimulating Factors
The Schepens Eye Research Institute, Inc.
0 cites - US116229512023Alpha-aminoadipate for Treatment of Vision Loss and Restoring Sight
The Schepens Eye Research Institute, Inc.
0 cites